Close

Goldman Expects Oncology M&A To Be Active In 2017, Sees (GILD), (JNJ), (PFE), (MRK), (NVS), (SNY), (LLY) As Possible Acquirers

January 4, 2017 6:40 AM EST Send to a Friend
Goldman Sachs analyst Salveen Richter expect an M&A uptick in 2017, with cancer remaining a focus. Richter notes after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login